Croda International/£CRDA

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Croda International

Founded in 1925, Croda International Plc is a UK-based speciality chemicals company recognized globally for its innovative approach to delivering specialized chemical solutions across a broad range of industries including consumer care and life sciences. Operating within the basic materials sector, Croda develops, manufactures, and markets a wide array of specialty chemicals used in everything from cosmetics and pharmaceuticals to lubricants and plastics. Over the decades, Croda has committed to sustainability and innovation, driving its growth and solidifying its position as in the industry.

Ticker

£CRDA
Sector

Primary listing

LSE

Industry

Chemicals

Employees

6,027

CRDA Metrics

BasicAdvanced
£4B
25.37
£1.14
0.76
£1.10
3.82%

What the Analysts think about CRDA

Analyst ratings (Buy, Hold, Sell) for Croda International stock.

Bulls say / Bears say

Croda International has opened a new advanced lipids manufacturing facility in Pennsylvania, USA, which is expected to enhance its production capabilities and meet growing demand in the pharmaceutical sector. (croda.com)
The company's Consumer Care unit, which includes fragrances and cosmetics, has shown signs of recovery with improved demand, indicating potential growth in this segment. (reuters.com)
Croda has maintained a strong balance sheet with a debt-to-equity ratio of 26.8% and an interest coverage ratio of 9.6, suggesting financial stability and capacity for future investments. (simplywall.st)
Croda anticipates a decline in profit and profit margins for 2024 due to ongoing customer destocking and subdued demand in its Crop Protection and Industrial Specialties segments. (reuters.com)
The company has reduced its annual profit expectations, citing weak demand in its life sciences unit, leading to a significant drop in share value. (reuters.com)
Croda's Return on Invested Capital (ROIC) stands at 6.2%, which is below the industry average of 11%, indicating potential inefficiencies in capital utilization. (alphaspread.com)
Data summarised monthly by Lightyear AI. Last updated on 7 Jul 2025.

CRDA Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

CRDA Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £CRDA

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs